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 During the past decade, the microbiologi-
cal quality of dialysis fl uid has become a 
matter of major concern for hemodialysis 
patients. 1 Ultrapurity of dialysis fl uid has 
emerged as a key component playing a 
major role in the overall biocompatibility 
of renal replacement therapy systems 
 (Figure 1). Microbial contaminants (bac-
teria and / or derived byproducts) of dialy-
sis fluid contribute to triggering and 
maintaining a low-grade infl ammation 
in hemodialysis patients by inducing 
monocyte / macrophage activation and the 
subsequent release of proinfl ammatory 
cytokines (interleukin-1, interleukin-6, 
and tumor necrosis factor). 2 It is now well 
established that chronic infl ammation is 
a key pathogenic actor in morbidity and 
mortality of hemodialysis patients. 
Infl ammation represents the main link 
amplifying the expression of uremic 
 toxicity and the severity of lesions in 
chronic kidney disease patients. 3 The 
pathogenic role of chronic microinfl am-
mation is multimodal: it enhances the 
progression of atherosclerosis and / or 
atheromatosis lesions; it amplifi es the vas-
cular and valvular calcifi cations associated 
with hyperphosphatemia; it worsens the 
malnutrition state, being responsible for 
protein energy wasting; it worsens the 
anemia by increasing the resistance to 
erythropoietin action and the production 
of hepcidin, which in turn reduces iron 
availability for erythropoiesis. 4 Prevention 
of chronic infl ammation induced by dial-
ysis fl uid contamination should be con-
sidered the main driving force supporting 
the regular use of ultrapure dialysate in 
contemporary hemodialysis. 5,6 European 
regulatory authorities and the European 
Renal Association were the fi rst to support 
this concept and implemented this new 
paradigm in the European Best Practice 
Guidelines. 7 Nowadays, ultrapurity of 
dialysis fl uid is recognized worldwide as a 
necessary step for further improving over-
all dialysis quality. National guidelines 
(France, Dutch, Japanese), including the 
North American ones (from the 
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 Association for the Advancement of Med-
ical Instrumentation), have incorporated 
this specifi c option in their latest issues. 8,9 
Moreover, virtually all dialysis manufac-
turers are providing cold sterilization of 
the dialysis fl uid by implementing a fi nal 
ultrafi lter in line on the dialysis machine. 
 In addition, two recent clinical rand-
omized trials suggest that further 
improvement in hemodialysis patient 
outcomes could be achieved by an 
increase in middle-molecule removal. A 
 post hoc analysis of the HEMO study 
assessing specifically the role of   2 -
microglobulin (B2M) concentrations in 
mortality has clearly shown that high 
B2M concentrations were associated 
with an increased risk of death in hemo-
dialysis patients. 10 Th e increase in the 
relative risk of death in the population 
studied was estimated to be 11 % per 
10  mg / l increase in predialysis B2M con-
centration for a threshold value of 
27  mg / l. The Membrane Permeability 
Outcomes study has recently shown that 
mortality of hemodialysis patients was 
signifi cantly reduced among high-risk 
patients (diabetics, hypoalbuminemic 
patients) with the use of a high-flux 
hemodialyzer. 11 Th e benefi cial eff ect of 
high-flux membrane use was not 
observed in low-risk patients when they 
received an adequate dialysis dose equiv-
alent for the two groups ( Kt / V urea >1.2). 
Although this study did not primarily 
address the role of B2M in patient mor-
tality, one might speculate that B2M con-
centrations were lower in the high-fl ux 
group. Th e potential benefi cial impact of 
increased middle-molecule clearance is 
also highlighted by recent studies evalu-
ating the eff ect of high-effi  ciency hemo-
diafi ltration on dialysis-patient survival. 
By combining diff usive and enhanced 
convective clearances, online hemodiafi l-
tration offers the most efficient renal 
replacement modality that maximizes 
middle-molecule clearance. Recent 
cohort studies have shown that the rela-
tive risk of mortality, accounting for 
dialysis dose and most comorbidities, was 
reduced by 35 % in patients treated with 
high-effi  ciency hemodiafi ltration. 12,13 In 
brief, these studies are in close agreement 
to suggest that combining the use of 
ultrapure dialysis fl uid and enhancement 
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in dialysis facilities and used as routine 
renal replacement therapy for all chronic 
kidney disease patients. A high volume 
of substitution fl uid, which is made pos-
sible with online production machines, 
was used in all patients to  maximize dialy-
sis-dose efficacy. The cold-sterilization 
process, using a final ultrafiltration of 
dialysis fluid, is safe, provided that the 
quality of the water feeding the dialysis 
machine is ensured, heat disinfection of 
the machine is performed after each 
treatment, and the ultrafi lter is changed 
periodically.
 Th e impact of highly effi  cient online 
hemodiafi ltration and ultrapure dialysis 
on morbidity and mortality of dialysis 
patients is currently under investigation 
in the Dutch CONTRAST study. Another 
randomized study evaluating patient 
 outcomes with high-fl ux hemodialysis 
versus high-effi  ciency hemodiafi ltration 
is currently running in France. 16 The 
results of both these studies are expected 
to be reported within the next three to 
four years. 
 To conclude, the nephrology commu-
nity is waiting for a defi nitive answer on 
the exact role of high convective clear-
ances and middle-molecule toxins and the 
regular use of ultrapure dialysis fl uid in 
chronic kidney disease patients ’ outcomes. 
In addition, the prospect of easy and per-
manent access to ultrapure dialysis fl uid 
permits us to envisage the development of 
new dialysis machines with total automa-
tion of priming and rinsing procedures 
incorporating biofeedback control of vol-
ume. Ultrapure dialysis fluid should 
become a new standard for contemporary 
hemodialysis machines. 
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of  middle- molecule clearance is signifi -
cantly benefi cial to patient outcomes. 
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nursing staff . 
 In brief, this study confi rms that ultra-
pure water and dialysis fl uid may be easily 
produced on a large, nationwide scale  and 
used in virtually all contemporary dialysis 
facilities. Relatively simple and compact 
technical solutions for water treatment 
have been developed for dialysis centers 
and could be mastered by specialized 
water and plumbing engineering manu-
facturers and bioengineers. Th e extra cost 
generated by this highly sophisticated new 
water treatment technology appears quite 
aff ordable and amortizable over the life 
duration of plant production of the water 
treatment system. 
In addition, the study by Penne  et al. 14 
confi rms that high-effi  ciency online hemo-
diafi ltration may be easily implemented 
 Figure 1  |  Dialysate ultrapurity produced by cold-sterilization process (ultrafiltration). 
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